Kansai nerolac paints Limited announced a significant change in its Board of Directors following a meeting held on February 3, 2026. The company disclosed the resignation of Executive Director Hirokazu Kotera, marking an important leadership transition.

Executive Director Resignation Details

Hirokazu Kotera, holding Director Identification Number 10707431, has submitted his resignation as Executive Director of the company. The resignation will take effect from the close of business on March 31, 2026.

Board Meeting Proceedings

The Board of Directors convened on Tuesday, February 3, 2026, to consider and approve the change in the Board composition. The meeting commenced at 1.50 p.m. and concluded at 6.30 p.m. During the session, the Board formally accepted Kotera's resignation and acknowledged his contributions during his tenure with the company.

Promoter Company Direction

The resignation stems from directions issued by Kansai Paint Co. Ltd., Japan, the promoter company that had originally nominated Kotera as a Director on the Board of Kansai Nerolac Paints Limited. This indicates a strategic decision by the parent company to restructure its representation on the Indian subsidiary's Board.

Regulatory Compliance

The company has fulfilled its disclosure obligations under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The announcement was made in compliance with Schedule III, Part A requirements and relevant SEBI circulars, ensuring transparency for stakeholders and market participants.

The resignation letter was formally submitted by Kotera to the Board of Directors, confirming his decision to step down from his executive role as directed by the Japanese parent company.

Kansai nerolac paints Limited has announced the grant of 3,313 Restricted Stock Units (RSUs) to selected employees under its RSU Plan 2022. The Nomination and Remuneration Committee (NRC) of the company approved this grant on 3rd February, 2026, with the grant date scheduled for 15th February, 2026.

RSU Grant Details

The newly granted RSUs are exercisable into 3,313 equity shares of the company with a face value of Re. 1 each, fully paid-up. This grant is part of the RSU Plan 2022, which was originally approved by the Board of Directors on 14th September, 2022, and by shareholders on 25th October, 2022.

Current RSU Plan Status

The company provided comprehensive details about the overall status of its RSU Plan 2022. The plan demonstrates significant employee participation with substantial vesting and exercise activity.

Plan Structure and Terms

The RSU Plan 2022 operates under the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. Each RSU carries the right to be issued one equity share of the company upon exercise. The vested RSUs must be exercised within four years from the date of vesting while in employment, with specific provisions for separation from employment as outlined in the plan.

The RSUs will vest according to the vesting schedule approved by the Nomination and Remuneration Committee. The pricing formula allows employees to acquire shares at face value as on the date of exercise, providing an attractive employee benefit structure.

Regulatory Compliance

This disclosure was made in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026. The announcement reflects the company's commitment to transparent communication with stakeholders regarding employee benefit programs.